Windy City Media Group Frontpage News

THE VOICE OF CHICAGO'S GAY, LESBIAN, BI, TRANS AND QUEER COMMUNITY SINCE 1985

home search facebook twitter join
Gay News Sponsor Windy City Times 2022-12-07
DOWNLOAD ISSUE
Donate

Sponsor

  WINDY CITY TIMES

AIDS: Dr. Phair: A warrior fighting HIV/AIDS
AIDS@30: A special series in partnership with the AIDS Foundation of Chicago
by Tully Satre
2011-09-14

This article shared 6472 times since Wed Sep 14, 2011
facebook twitter pin it google +1 reddit email


In the field of HIV/AIDS, Chicago-based Dr. John Phair is a familiar name.

He spearheaded research with the National Institute of Health/National Institute of Allergy and Infectious Diseases' Multicenter AIDS Cohort Study ( MACS ) in 1983. MACS provided groundbreaking contributions to understanding HIV/AIDS through studying the natural and treated history of the HIV infection.

He applied for and received funding from the NIAID to establish the Chicago Adult AIDS Clinical Trials Unit in 1987. Phair served as the Chair of the Executive Committee of the Adult AIDS Clinical Trials Group, overseeing the scientific, administrative, and fiscal decisions of the network during the early stages of therapy.

He was the Chair for the AIDS Research Advisory Committee for the NIAID from 2000 to 2002.

In 2005, Phair was honored by the American College of Physicians with the John Phillips Memorial Award for Outstanding Work in Clinical Medicine. It was certainly not the first time Phair was recognized for his extraordinary impact on HIV/AIDS treatment and research, and would surely not be the last. In the Spring of 2010 Phair became the first recipient of the International AIDS Society—USA Lifetime Leadership Award.

"My interests were focused mainly on complications of HIV infection," said Phair about when he first became involved in treating HIV/AIDS patients. "When HIV infects and you can't treat it, it destroys the ability of the body to resists other infections."

Much of Phair's work was not directly with the virus, but with the complications that resulted from infection.

After graduating from Yale University, Phair attended medical school in his hometown at the University of Cincinnati College of Medicine. Upon completing his studies in 1960, Phair returned to Connecticut to do his residency at the Yale New Haven Hospital where he first began training in internal medicine and infectious disease.

"This was a part of medicine in which we had treatment," Phair explained of the work he started during his residency. "So people basically did well. We could manage to make people better."

In 1967, he joined the faculty at the University of Cincinnati College of Medicine, where he remained for just under a decade before accepting the position of Chair of the Division of Infectious Disease and Director of the Samuel J. Sackett Laboratories at the Fineberg School of Medicine at Northwestern University.

"My research prior to my involvement with HIV was focused upon the immunology of infections," Phair said. "David Ostrow [ who helped form the Howard Brown Health Center ] approached me and asked whether I knew anything about this disease that was killing gay men. I had seen a couple of cases at Northwestern, but because of my immunology research, I was interested."

Before encountering HIV/AIDS, most of the infectious diseases Phair worked with were easily treated with antibiotics or other medicines. "AIDS came along and it became apparent that there was no longer treatment," Phair recalled. "In that period because of fear and the novelty of [ HIV/AIDS ] , infectious diseases at Northwestern became the group who managed patients who came to Northwestern with what we came to know as AIDS."

Initially, Phair helped carry out a small study at the Howard Brown Health Center ( then known as Howard Brown Memorial Clinic ) , which did not yield substantial results. However, it lead to an application to the National Institute of Health, and in 1983, with Dr. Ostrow spearheading the move, the NIH started the Multicenter AIDS Cohort Study ( MACS ) . Dr. Phair was appointed principal investigator of the Chicago part of the study, which worked in collaboration with other researchers and investigators around the country.

"AIDS was basically a change in the whole focus of infectious disease," Phair said, recalling the shift in thought that AIDS had on the medical field. "Before [ HIV/AIDS ] we had been consultants; we saw patients and we would recommend therapy and they would get better. Now we became the primary care physicians for a group of people who we could not really do anything for."

"We had to care for people, rather than treat people," said Phair. "It was a shock in the 1980s not to be able to do something for somebody … it was a very tough time." Phair said that most patients with AIDS at Northwestern were gay men. "All of us were impressed by their grace, and courage," Phair said of his early patients, "and altruism … wanting to participate in research to respond to this epidemic."

For the first six to seven years, there was very little that could be done to help patients with AIDS. "All we could really do was hold their hand," said Phair.

In 1987, Dr. Phair applied for funding from the National Institute of Allergy and Infectious Diseases ( a division of the NIH ) to open a center for experimental treatment in Chicago. The center was setup at Northwestern in relationship with Rush Medical and was a part of the larger AIDS Clinical Trials Group, a network of more than 30 universities, which was established by the NIH. The Chicago Adult AIDS Clinical Trials Unit was established on the horizon of successful treatments for people living with HIV/AIDS. The introduction of AZT to the pharmaceutical market was a breakthrough, "but not perfect," Phair emphasized.

AZT alone did not make much of an impact and it often came with many side effects. It was not until 1995 that new drugs were introduced, which combined with existing drugs at the time provided a treatment that controlled the virus, if taken religiously.

"The initial cocktails were very difficult to take," said Phair. "Drugs today are better, with less side effects. And they're easier to take: one pill, once a day as opposed to the 15 to 20 pills a day in 1995."

But even the safer drugs still have side effects, Phair warns. As HIV infections continue to rise, particularly among a young MSM ( men-who-have-sex-with-men ) demographic, Phair stressed the importance of being safe. "Even though life expectancy is closer to what you'd expect if you weren't infected … life is still shortened a little bit," said Phair. Additionally there are several complications that result from side effects of drugs used today to treat HIV including heart, kidney and liver diseases. "While the drugs suppress the virus," Phair explained, "some of the deleterious effects of HIV infection continue [ and ] chronic infection can lead to complications."

Recent studies across the board have continued to show a dramatic increase in HIV infections for men who have sex with men, particularly among men their 20s. "I think in the '80s when men saw their friends dying it made an impact," Phair said. "The men who were alive and survived those early days are older and the younger men [ today ] don't have that experience. They're not seeing their friends die, so they sometimes don't buy into the message of the necessity of safe-sex and safe behaviors in general. They also think the drugs [ used to treat HIV ] solve things … and people get tired of being careful. There has been some slippage of safe behavior. I think we still have a great number of people with new infections who are gay men."

After 30 years, the response to the disease once dubbed "gay cancer" has seen great progress due to the efforts of people such as Dr. Phair. But the responsibility for the disease has shifted on a different generation.

Demonstrating numerous accomplishments and contributions to HIV/AIDS research, Phair officially stepped down in 2000 as head of the Division of Infectious Disease, and the Samuel J. Sackett Laboratories at the Feinberg School of Medicine at Northwestern University. Dr. Phair continues to work with MACS, but no longer takes responsibility for the treatment center.

Still active today, MACS, which moved to Northwestern after funding controversies at Howard Brown Health Center in 2010 ( HBHC is now a subcontractor ) , is the longest running study of people living with HIV/AIDS. With nearly 7,000 initial participants, MACS studied the long-term effects of HIV and treatment in gay men. As of 2009, the study enrolled just above 2,500 participants, with several of the participants having passed away from AIDS-related illnesses, or having dropped out altogether.

MACS boasts a number of contributions to the fight against HIV/AIDS including more than 1100 peer reviewed publications, which have greatly increased awareness and understanding of HIV/AIDS.


This article shared 6472 times since Wed Sep 14, 2011
facebook twitter pin it google +1 reddit email

  ARTICLES YOU MIGHT LIKE

Gay News

AFC's World of Chocolate on Feb. 17 2023-01-02
- After a nearly three-year hiatus, AIDS Foundation Chicago (AFC) will host the return of its famed World of Chocolate fundraiser on Friday, Feb. 17, at Union Station, 225 S. Canal St. This event features a menu ...


Gay News

Chicago activist Jeff Berry discusses advocacy for aging persons living with HIV 2022-12-08
- For longtime Chicago activist Jeff Berry, becoming the first executive director of the Reunion Project—a national alliance centering aging persons living with HIV, which Berry co-founded in 2015—was a significant ...


Gay News

Annual STRUT event shines spotlight on World AIDS Day 2022-12-07
- On the evening of Nov. 4, the annual STRUT fashion show celebrated its 13th edition at Joe's on Weed St. As in the past, STRUT shined its spotlight on up-and-coming young fashion designers while raising funds for ...


Gay News

PRCC-VIDA/SIDA event marks World AIDS Day with Vigil and Baton show 2022-12-05
- On Dec. 1, the Puerto Rican Community Center (PRCC) and Vida/SIDA celebrated World AIDS Day with a candlelight vigil in the afternoon and a commemorative show at The Baton Show Lounge in the evening. The earlier ...


Gay News

Chicago's sweetest party and fundraiser, World of Chocolate returns In-person Feb. 17 at Union Station 2022-12-05
-- From a press release - CHICAGO — Glitz, glamour and chocolate…after a nearly three-year hiatus, AIDS Foundation Chicago (AFC) proudly announces the return of its famed World of Chocolate fundraiser on Friday, February 17 at Union Station ...


Gay News

Cleve Jones, founder of AIDS Memorial Quilt, honored with Lifetime of Commitment Award on World AIDS Day 2022-12-03
-- From a press release - SAN FRANCISCO, CA (Nov. 30 & Dec. 1, 2022) — The National AIDS Memorial marked World AIDS Day with a national observance at the 10-acre National AIDS Memorial Grove in San Francisco, honoring AIDS activist and founder of the AIDS Memorial Quilt ...


Gay News

Pritzker administration announces highly effective HIV treatment coming to Illinois in 2023 2022-12-02
-- From a press release - CHICAGO — Governor JB Pritzker and the Illinois Department of Public Health (IDPH) announced today on World AIDS Day that a new, long-acting HIV treatment called Cabenuva will become available to thousands of ...


Gay News

World AIDS Day: GLAAD releases 2022 State of HIV Stigma Study 2022-12-01
-- From a press release - (New York, NY - December 1, 2022) GLAAD, the world's largest lesbian, gay, bisexual, transgender and queer (LGBTQ) media advocacy organization, is releasing its third annual State of HIV Stigma ...


Gay News

Peppermint barks while Broadway bangs, and all the other dish to start the week 2022-11-28
- "I love Broadway. I love what they do—Broadway Cares, but I also want to say the show is extraordinary!" —Nicole Kidman's impromptu speech after bidding $100K to Broadway Cares/Equity Fights AIDS for Hugh Jackman's hat after ...


Gay News

Lambda Legal challenges anti-HIV military policy 2022-11-13
- Lambda Legal filed a legal challenge to the U.S. military policy that prevents people living with HIV from enlisting in the U.S. Armed Forces, according to a press release. The current policy requires that applicants for ...


Gay News

National AIDS Memorial names 2022-2023 Pedro Zamora Young Leaders Scholarship recipients 2022-11-09
-- From a press release - SAN FRANCISCO, California, Nov. 09, 2022 (GLOBE NEWSWIRE) — The National AIDS Memorial has announced its 2022/2023 Pedro Zamora Young Leaders scholars, its largest and most diverse class ever, providing ...


Gay News

Sheryl Lee Ralph producing HIV/AIDS documentary 2022-10-29
- Recent Emmy winner Sheryl Lee Ralph has signed on to produce Unexpected, a documentary short about women of color living with HIV in the South, Variety reported. Directed by Zeberiah Newman, the film will chronicle Masonia ...


Gay News

LGBTQ+ HISTORY MONTH Podcast sheds light on forgotten murders of gay men in Montreal 2022-10-22
- When people ask about or Google the murders of gay men in Montreal in the '90s, it all leads to the podcast "The Village: The Montreal Murders." LGBTQ+-rights advocates encouraged me to listen to the podcast. ...


Gay News

ViiV announces recipients of largest U.S. fund for HIV prevention in Black women 2022-10-10
- ViiV Healthcare announced the recipients of an $8-million investment to increase awareness and action around HIV prevention and care for Black women, according to a press release via CSR Wire. Funding will support community programs focused ...


Gay News

CDPH report: New HIV, AIDS diagnoses at lowest points since the 1980s; other STIs rise 2022-10-06
-- From a press release - CHICAGO — The number of Chicagoans newly diagnosed with HIV and AIDS in 2020 was at the lowest level in four decades, according to a comprehensive new HIV and STI (sexually transmitted infections) report from the ...


 




Copyright © 2023 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 
 

TRENDINGBREAKINGPHOTOS







Sponsor


 



Donate


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots
Identity      BLACKlines      En La Vida      Archives      Advanced Search     
Windy City Queercast      Queercast Archives     
Press  Releases      Join WCMG  Email List      Email Blast      Blogs     
Upcoming Events      Todays Events      Ongoing Events      Bar Guide      Community Groups      In Memoriam     
Privacy Policy     

Windy City Media Group publishes Windy City Times,
The Bi-Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.